IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ally Bridge Group (NY) LLC

Q4 2024 Holdings

Filed 2025-02-14 | 30 holdings | $116.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intra-Cellular Therapies Inc(ITCIEUR)COM46116X101$12.3M147,75010.6%
Tarsus Pharmaceuticals Inc(TARS)COM87650L103$9.6M173,1448.2%
Insmed Inc(INSM)COM PAR $.01457669307$7.9M114,3606.8%
Axsome Therapeutics Inc(AXSM)COM05464T104$5.6M66,6614.8%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$5.1M129,2914.3%
CG Oncology Inc(CGON)COM156944100$5.0M174,0484.3%
Merus N VCOMN5749R100$4.9M116,7964.2%
Blueprint Medicines Corp(2L9)COM09627Y109$4.9M55,8924.2%
Janux Therapeutics Inc(JANX)COM47103J105$4.8M90,2924.1%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$4.1M244,5383.5%
Soleno Therapeutics Inc(SLNO)COM834203309$3.9M87,6293.4%
Geron Corp(GERN)COM374163103$3.8M1,074,8243.3%
Alumis Inc(ALMS)COM022307102$3.5M445,2593.0%
Praxis Precision Medicines I(PRAX)COM NEW74006W207$3.5M44,9823.0%
Trevi Therapeutics Inc(TRVI)COM89532M101$3.2M781,4892.8%
Enliven Therapeutics Inc(ELVN)COM29337E102$3.2M141,7102.7%
Korro BIO Inc(KRRO)COM500946108$2.7M70,6782.3%
Jasper Therapeutics Inc(JSPR)COM NEW471871202$2.6M122,4242.2%
Eyepoint Pharmaceuticals Inc(EYPT)COM NEW30233G209$2.6M348,0002.2%
Aadi Bioscience Inc(WHWK)COM00032Q104$2.6M817,9392.2%
Atyr Pharma Inc(ATYR)COM NEW002120202$2.5M699,7302.2%
89Bio Inc(ETNBGBP)COM282559103$2.5M317,8332.1%
Tyra Biosciences Inc(TYRA)COM90240B106$2.4M175,0632.1%
Dianthus Therapeutics Inc(DNTH)COM252828108$2.3M106,4342.0%
Mind Medicine Mindmed Inc(BRD1EUR)COM NEW60255C885$2.3M330,2752.0%
Edgewise Therapeutics Inc(EWTX)COM28036F105$2.2M83,1761.9%
Springworks Therapeutics IncCOM85205L107$2.0M54,6921.7%
Context Therapeutics Inc(CNTX)COM21077P108$1.7M1,576,7621.4%
Promis Neurosciences Inc(PMNEUR)COM NEW74346M406$1.5M1,592,6051.3%
Climb BIO Inc(CLYM)COM28658R106$1.4M760,2251.2%